InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
2
T+90 胜率
0%
T+90 平均收益
-18.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by MacKay-Dunn R. Hector, 董事. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. In total, 6 reports have been published. Breakdown: 2 buys · 2 sells. Total volume traded: €135k. Activity tracked since 11 May 2021. The latest transaction was filed on 21 May 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to MacKay-Dunn R. Hector
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
5,630 股@ US$5.7421.3% 占其流量Common StockSEC:0001600620-24-000070:0
8,733 股Common StockSEC:0001600620-23-000018:0
4,818 股@ US$11.2636.0% 占其流量Common StockSEC:0001600620-23-000018:2
9,310 股0Common StockSEC:0001600620-23-000018:1
5,000 股@ US$10.9970.0024% mcap84.6% 占其流量Common StockSEC:0001628280-22-005882:0
标准退出：2022年6月7日 (T+90)
500 股@ US$11.173.4% 占其流量Common StockSEC:0001628280-21-010163:0
标准退出：2021年8月9日 (T+90)
6 条申报中的 6 条
About MacKay-Dunn R. Hector
Hector R. MacKay-Dunn is a Board Member at Aurinia Pharmaceuticals Inc. He plays an essential role in the governance of the company, overseeing operations and contributing to growth strategy.
